Chronic allograft nephropathy (CAN) represents an important cause of graft loss after kidney transplantation. TGF-beta1 is a key factor in fibrogenesis, and the angiotensin II receptor antagonist losartan may decrease the intra-graft synthesis of TGF-beta1. The aim of this study was to determine the clinical and molecular effect of losartan in kidney transplant patients (KTPs) with CAN. We studied nine KTPs, after the first year of transplantation, with proteinuria (more than 500 mg/24 h), stable renal function, and histological signs of CAN. Immunosuppression was cyclosporine, azathioprine, and corticoids. Kidney biopsy was performed in all patients at the beginning of the study and 12 weeks after treatment with 50 mg/day of losartan. Quantitation of intra-graft expression of TGF-beta1 was performed in all biopsies, by real-time PCR. After losartan treatment there were no differences in patients' BP and blood creatinine level. The proteinuria significantly dropped to 414.2+/-377 mg/24 h, P=0.001. Intra-graft expression of TGF-beta1 was decreased after treatment. In conclusion, losartan significantly decreases the intra-graft expression of TGF-beta1 and proteinuria in KTPs with CAN.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00147-004-0740-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intravital Two-Photon Microscopy of the Transplanted Mouse Lung.
J Vis Exp
April 2024
Division of Cardiothoracic Surgery, Washington University in St. Louis;
Complications after lung transplantation are largely related to the host immune system responding to the graft. Such immune responses are regulated by crosstalk between donor and recipient cells. A better understanding of these processes relies on the use of preclinical animal models and is aided by an ability to study intra-graft immune cell trafficking in real-time.
View Article and Find Full Text PDFLong-Term Survival and Induction of Operational Tolerance to Murine Islet Allografts by Co-Transplanting Cyclosporine A Microparticles and CTLA4-Ig.
Pharmaceutics
August 2023
Alberta Diabetes Institute, University of Alberta, Edmonton, AL T6G 2E1, Canada.
One strategy to prevent islet rejection is to create a favorable immune-protective local environment at the transplant site. Herein, we utilize localized cyclosporine A (CsA) delivery to islet grafts via poly(lactic-co-glycolic acid) (PLGA) microparticles to attenuate allograft rejection. CsA-eluting PLGA microparticles were prepared using a single emulsion (oil-in-water) solvent evaporation technique.
View Article and Find Full Text PDFSingle-Cell RNA Sequencing Identifies Intra-Graft Population Heterogeneity in Acute Heart Allograft Rejection in Mouse.
Front Immunol
April 2022
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Article Synopsis
- Transplant rejection is a significant obstacle for graft survival, influenced by various cell types, yet their specific roles in rejection are not well understood.
- Using single-cell RNA sequencing, this study investigated the different cell populations in a mouse heart transplant model during acute rejection.
- Results identified 21 unique cell populations, with key findings showing active infiltrating macrophages and a specific endothelial cell group linked to rejection, suggesting these could be potential biomarkers for clinical rejection prediction.
delivery of regulatory T-cells for control of alloimmune priming in the donor lung.
Eur Respir J
April 2022
Latner Thoracic Surgery Research Laboratories, University Health Network, University of Toronto, Toronto, ON, Canada
Background: Survival after lung transplantation (LTx) is hampered by uncontrolled inflammation and alloimmunity. Regulatory T-cells (Tregs) are being studied as a cellular therapy in solid organ transplantation. Whether these systemically administered Tregs can function at the appropriate location and time is an important concern.
View Article and Find Full Text PDFAstrocytes migrate from human neural stem cell grafts and functionally integrate into the injured rat spinal cord.
Exp Neurol
April 2019
Department of Neurosciences, University of California - San Diego, La Jolla, CA, USA; VA San Diego Healthcare System, San Diego, CA, USA. Electronic address:
Neural stem cells (NSCs) can differentiate into both neurons and glia after transplantation into spinal cord injury (SCI) sites. The neuronal component of stem cell grafts has the potential to form functional synaptic relays across the lesion site. The glial component may reform a blood-spinal cord barrier, support neuronal function, and contribute to remyelination.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!